Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Edward D. Blair"'
Autor:
Christopher J.A. Ring, Edward D. Blair
Publikováno v:
Genetically Engineered Viruses ISBN: 9781003423775
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0b9105c712a683e268ea2f7bade861f
https://doi.org/10.1201/9781003423775-1
https://doi.org/10.1201/9781003423775-1
Publikováno v:
Journal of Personalized Medicine, Vol 2, Iss 4, Pp 257-266 (2012)
The twin forces of payors seeking fair pricing and the rising costs of developing new medicines has driven a closer relationship between pharmaceutical companies and diagnostics companies, because stratified medicines, guided by companion diagnostics
Externí odkaz:
https://doaj.org/article/5b4e82b073bb459b96dfb131cbfc1d16
Publikováno v:
Personalized Medicine. 15:45-56
Targeted therapies continue to be key components of cancer treatment. New approaches to detection of acquired resistance at the genomic level, in combination with new therapies, help to overcome the challenges that are seen frequently, rapidly and br
Publikováno v:
Personalized Medicine. 12:389-402
Medical history has not wandered far from its original aspirations of being personalized. Diagnostic capability has evolved from the metaphysical to the anatomical to the cellular and ultimately to the molecular level. Now that diseases can be subcla
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 2, Iss 4, Pp 257-266 (2012)
Journal of Personalized Medicine, Vol 2, Iss 4, Pp 257-266 (2012)
The twin forces of payors seeking fair pricing and the rising costs of developing new medicines has driven a closer relationship between pharmaceutical companies and diagnostics companies, because stratified medicines, guided by companion diagnostics
Autor:
Jamie R Love, Edward D Blair
Publikováno v:
Intellectual Property Rights: Open Access. 4
The economic value of intellectual property associated with prognostic and predictive tests is being increasingly recognised, such that some tests with established impact on healthcare pathways can command a premium reimbursement price from payers. H
Publikováno v:
Personalized Medicine. 8:517-521
The UK healthcare system holds a favorable position in the development of stratified medicines through strong scientific innovation, robust biotechnology and pharmaceutical industries and comparatively simple regulatory and reimbursement processes. O
Autor:
Edward D Blair
Publikováno v:
Personalized Medicine. 7:143-161
Acceptance and operation of a personalized medicine strategy within modern healthcare requires that all key stakeholders are able to understand and assess the benefits offered by the approach. In addition to the technological aspects of molecular dia
Autor:
Edward D. Blair
Publikováno v:
Molecular Diagnosis & Therapy. 12:331-337
We explore the cash value of the companion diagnostics opportunity from the perspective of the pharmaceutical partner. Cashflow-based modeling is used to demonstrate the potential financial benefits of key relationships between the pharmaceutical and
Autor:
R. A. Killington, Tobias J. Tuthill, Lisa J. Challinor, Sebastian L. Johnston, Nigel A. Sharp, Jerome Burnet, Neil J. Clarke, Edward D. Blair, Laura Dash, Suzanne Barnard, David J. Rowlands, Nikolaos G. Papadopoulos, Chris Plumpton, Ketaki Shah, Patrick Jourdan
Publikováno v:
Journal of General Virology. 84:2829-2836
Human rhinoviruses (HRV) are responsible for the majority of virus infections of the upper respiratory tract. Furthermore, HRV infection is associated with acute exacerbation of asthma and other chronic respiratory diseases of the lower respiratory t